Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ascent Solar Technologies Reflects on H1 2025 Achievements and Milestones, Looks Ahead to Executing Upon H2 2025 Strategy
-
DemandScience Launches Digital Audiences for Multi-Channel Account- and Persona-Based Targeting
-
Intermex Launches a new Remittance-as-a-Service (RaaS) Platform to Help Businesses Simplify Cross-Border Payments
-
Rachael Haher Named Chief Operating Officer of TRU Staffing Partners
-
Hope Cancer Care of Nevada and American Oncology Network Open New Henderson Clinic
-
Sysco to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 29
-
Changes in Nokia Corporation's own shares
-
Sergei Guriev, Dean of London Business School, Joins the Group of Thirty
-
Bitcoin Solaris Advances Toward Market Launch with Strategic Exchange and Rollback Update
-
Lucinity Achieves Microsoft Certified Software for Financial AI
-
ZyVersa Therapeutics Supports FDA-Authorized Emergency Compassionate Use of Cholesterol Efflux Mediator™ VAR 200 in a Patient with ApoCII Amyloidosis
-
Form 8.3 - [Marlowe plc - Octopus Investments
-
ReserveOne Sets Out to Build the Digital Reserve of the Future
-
POET Technologies Announces Appointment of Sohail Khan as Director
-
Jeffs’ Brands Announces Closing of Acquisition Transaction: Fort Technology Inc. Expected to Resume Trading on TSX Venture Exchange
-
Martin Marietta Appoints Michael J. Petro as Chief Financial Officer
-
BriaCell Phase 2 Survival Achievement: 52% of Patients Surpass One-Year Milestone in Metastatic Breast Cancer
-
Matador Technologies to Launch “Grammies” – A Digital Gold Product on the Bitcoin Blockchain
-
Dynacor Signs Share Purchase Agreement to Acquire Processing Plant and Assets in Ecuador
-
Habit Burger & Grill’s “Hot Dads” Calendar is Here. Order Now to Get it by August 1
-
MariMed Announces Second Quarter 2025 Earnings Date
-
Plus Therapeutics Announces Initial Patients Successfully Treated in ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases
-
Stallion Uranium Enters into Technology Data Acquisition Agreement
-
Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer
-
Habit Burger & Grill’s “Hot Dads” Calendar is Here. Order Now to Get it by August 1
-
Bread Financial Schedules Second Quarter 2025 Earnings Conference Call for July 24
-
Innova completes sale of Wrexham Solar Park to Atrato Onsite Energy
-
Net Asset Value(s)
-
Sanborn Geophysics Doubles Production, Launches Upgraded Product Line, and Prepares Move to Purpose-Built Facility
-
CANADA CARBON ANNOUNCES RECEIPT OF NECESSARY PERMITS FOR ITS THIRD DRILLING CAMPAIGN ON ASBURY GRAPHITE PROPERTY
-
Endeavour Silver Produces 1,483,736 Oz Silver and 7,755 Oz Gold (2.5 Million Silver Equivalent Oz) in Q2 2025
-
Edf: EDF group governance changes
-
Willis launches $200m facility to tackle global geopolitical uncertainty for cargo owners
-
NexGold Receives Schedule 2 Amendment Approval for Goldboro Gold Project
-
H2O America Significantly Expands Texas Footprint with Texas Subsidiary’s Acquisition of Quadvest
-
Calian Reinforces Support for Canadian Armed Forces with $250M Contract Amendment
-
Nobel Resources Announces Additional Results at the Cuprita Project, Atacama Region, Chile
-
Agios Appoints Dr. Jay Backstrom to Board of Directors
-
CervoMed Announces Late-Breaking Presentations at Alzheimer’s Association® International Congress 2025
-
Larimar Therapeutics Publishes Nonclinical Data Supporting the Therapeutic Potential of Nomlabofusp in Patients with Friedreich’s Ataxia
-
Upstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)
-
Churchill Reports High-Grade Zinc Results on Polymetallic Veins at the Black Raven Property, Central Newfoundland
-
Eupraxia Doses First Patient in Phase 2b Placebo-Controlled Portion of EP-104GI RESOLVE Trial in Eosinophilic Esophagitis
-
Plymouth Industrial REIT Provides Activity Update for Second Quarter 2025
-
Microbix & Bulgaria’s NCIPD Execute Supply Agreement
-
Jade Biosciences to Participate in Two Upcoming Investor Conferences
-
Mercury Receives Two New Common Processing Architecture Production Awards
-
Xtract One Selected by Mecklenburg County Public Schools to Enhance Building Security District-Wide
-
ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
-
ROM: Golden Age Blasts Past 500,000 Pre-Registrations - Join the Buddy Boost Lottery for a Shot at Massive Crypto Prizes
